| 000 | 01095 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513110751.0 | ||
| 264 | 0 | _c19970114 | |
| 008 | 199701s 0 0 eng d | ||
| 022 | _a0167-5699 | ||
| 024 | 7 |
_a10.1016/0167-5699(96)80556-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRöcken, M | |
| 245 | 0 | 0 |
_aIL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. _h[electronic resource] |
| 260 |
_bImmunology today _cMay 1996 |
||
| 300 |
_a225-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAutoimmune Diseases _ximmunology |
| 650 | 0 | 4 |
_aEpitopes _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypersensitivity, Delayed _xprevention & control |
| 650 | 0 | 4 |
_aImmunotherapy _xtrends |
| 650 | 0 | 4 |
_aInterleukin-4 _ximmunology |
| 700 | 1 | _aRacke, M | |
| 700 | 1 | _aShevach, E M | |
| 773 | 0 |
_tImmunology today _gvol. 17 _gno. 5 _gp. 225-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0167-5699(96)80556-1 _zAvailable from publisher's website |
| 999 |
_c8982764 _d8982764 |
||